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Over the last three decades, hospital adapted clonal complex (CC) 17 strains of Enterococ-
cus faecium have acquired and exchanged antimicrobial resistance genes leading to the
widespread resistance to clinically important antimicrobials globally. In Australia, a high
prevalence of vancomycin resistance has been reported in E. faecium in the last decade.
Methods
In this study, we determined the phylogenetic relationship and genetic characteristics of E.
faecium collected from hospitalized patients with blood stream infections throughout Austra-
lia from 2015 to 2017 using high throughput molecular techniques.
Results
Using single nucleotide polymorphism based phylogenetic inference, three distinct clusters
of isolates were observed with additional sub-clustering. One cluster harboured mostly non-
CC17 isolates while two clusters were dominant for the vanA and vanB operons.
Conclusion
The gradual increase in dominance of the respective van operon was observed in both the
vanA and vanB dominant clusters suggesting a strain-van operon affinity. The high preva-
lence of the van operon within isolates of a particular sub-cluster was linked to an increased
number of isolates and 30-day all-cause mortality. Different dominant sub-clusters were
observed in each region of Australia. Findings from this study can be used to put future sur-
veillance data into a broader perspective including the detection of novel E. faecium strains
in Australia as well as the dissemination and evolution of each strain.
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Introduction
Enterococcus faecium is a species of Gram-positive bacterium most commonly found as a com-
mensal of the mammalian gut microbiome. However not all E. faecium strains exists solely as
commensals, with some harbouring the ability to cause invasive infections [1]. In patients with
bacteraemia, the vast majority (>90%) of enterococci identified were either E. faecalis or E.
faecium. Although E. faecalis are more often responsible for infections, it is the nosocomial E.
faecium infections that are typically resistant to multiple antimicrobial classes.
The E. faecium responsible for the majority of hospital acquired infections consists of vari-
ous sequence types (STs) related to clonal complex (CC) 17 [2]. The acquisition of vancomycin
resistance genes in CC17 is of serious concern as vancomycin is also used for the treatment of
other Gram-positive bacterial infections including methicillin-resistant Staphylococcus aureus
[3]. Of the known van genotypes conferring vancomycin resistance, the vanA, vanB and vanM
genotypes have the greatest clinical significance as they confer intermediate to high levels of
resistance and reside on genetic elements that can not only be transferred within enterococci
but to other bacteria [4–6].
To ensure antimicrobial agents provide the best treatment outcomes with minimal risk of
adverse effects, including the development of antimicrobial resistance [7], robust surveillance
of antimicrobial resistant bacteria is required. In Australia, the Australian Group on Antimi-
crobial Resistance’s (AGAR) Australian Enterococcal Sepsis Outcome Program (AESOP)
closely monitors enterococcal isolates from episodes of blood stream infection (BSI) across the
country. In the 2015, 2016 and 2017 AESOPs the percentage of E. faecium BSIs that were van-
comycin resistant was 46.5%, 50.1% and 47.0%, respectively [8–10]. Compared to the popula-
tion-weighted mean of 8.3%, 11.8% and 14.2% for nations within the European Economic
Area over the same time period [11–13], the high prevalence of vancomycin-resistant E. fae-
cium (VREFm) BSIs in Australia represents a serious public health concern [14].
To understand the high prevalence of nosocomial VREfm causing enterococcal bacteraemia
in Australia, a whole genome sequencing (WGS) bioinformatics approach was used to deter-
mine the relationship and characteristics of E. faecium isolates from the 2015, 2016 and 2017
AESOPs.
Methods
Isolates were sourced from the 2015, 2016 and 2017 AGAR AESOPs. As part of the AESOPs,
enterococcal isolates were referred to a central reference laboratory where WGS was performed
on all E. faecium isolates. Libraries for WGS were prepared with the Illumina1Nextera1 XT
DNA Library Prep Kit (Illumina, United States) according to the prescribed protocol. Sequenc-
ing was performed on either the Miseq™ or NextSeq™ platform using the 600-cycle Reagent
Kit v3 and the 300-cycle mid output Reagent Kits v2 respectively. As part of quality control,
sequence data of isolates yielding less than 40x depth and 50% coverage to the reference chro-
mosome of E. faecium Aus0004 (GenBank CP003351), were excluded from the study.
For each isolate, raw sequencing reads were cleaned using Trimmomatic V0.38 [15] before
being assembled by SPAdes V3.12.0 [16] followed by gene identification and annotation by
Prokka V1.13 [17]. Pan genome analysis was performed using Roary V3.12.0 [18] on Prokka
generated files. Virulence and resistance genes were identified using ABRicate V0.8.7 in tan-
dem with VFDB (21/01/2019) [19] and the ResFinder (21/01/2019) [20] databases respectively.
Positive identification of resistance genes and virulence factors were indicated by a minimum
sequence homology of 85% to respective database entries. Analysis of the esp virulence factor
was excluded from this study due to the limitations of the sequencing methodology in resolv-
ing repeat regions within the esp gene [21]. Functional van operons were determined by the
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presence of regulation genes (vanR and vanS) and essential genes (vanH, vanA/vanB, vanX)
within the respective vanA or vanB operon. The ST for each isolate was determined using the
scheme described by Homan et al. [22] with sequence definitions hosted on the BIGSdb
(https://pubmlst.org/software/database/bigsdb/) database [23]. Isolates with one or more
ambiguous MLST alleles were categorized as undefined and excluded from the study. The
BURST diagram describing the relationship of STs was constructed using eBURST V3 [24].
Single nucleotide polymorphisms (SNPs) were identified using Snippy V4.1.0 [25]. Removal
of recombinant DNA segments was performed on SNP alignments using ClonalFrameML
V1.11 [26]. Phylogenetic trees were constructed using the maximum likelihood method based
on the SNP alignments in RAxML V8.2.11 [27] with the GTRCAT model and bootstrap
values set at 1000. The main phylogenetic tree was constructed using all isolates with the root
placed the most distantly related isolate. The most distantly related isolate was determined by
SNP inferred phylogeny of isolates with a distantly related reference from the E. durans species
(Accession: CP012366). Clusters were determined based on distinct phylogenetic branches
observed. To enhance SNP resolution in major branches of the main phylogenetic tree, SNP
analysis was repeated on subsets of isolates labelled as clusters. Individual cluster phylogeny
was analysed using the previously described method with the root placed at the most distantly
related isolate determined by the main phylogenetic tree. Further sub-clustering was per-
formed based on distinct branches of each phylogenetic tree. The iTOL V3 [28] web service
was used to visualize the phylogenetic tree along with the metadata.
All statistical analysis were performed with the statistical package R [29]. The association
between clusters and mortality were investigated using generalised linear regression model
(GLM). Odds ratios and confidence intervals were calculated from the GLM model with p-
values� 0.05 considered significant.
No ethics approval was required
Nucleotide sequences of isolates from AGAR AESOP 2015, 2016 and 2017 have been deposited
in the sequence read archive under BioProject IDs: PRJNA562395, PRJNA562414 and
PRJNA5662407 respectively.
Results
From 1st January 2015 to 31st December 2017 1,296 E. faecium BSI isolates were collected in the
AGAR AESOPs. WGS quality control excluded 266 isolates and an additional five isolates were
excluded due to ambiguous MLST alleles (two isolates with multiple copies of an allele and
three isolates with truncated alleles). The remaining 1,025 isolates (332 in 2015, 320 in 2016
and 373 in 2017) were used in the study. The average genome size of isolates was 2,974,436bp
with a standard deviation of 269,356bp. The average number of genes per isolate was 2,789
with a standard deviation of 244.
For the 1,025 episodes of E. faecium bacteraemia, the average patients age was 64 years with
an interquartile range of 55 and 77. The male to female ratio was approximately 1.6 and when
known, the 30-day all-cause mortality was 26.2%.
E. faecium isolates were collected from all Australian states and mainland territories: New
South Wales (NSW) 352 isolates; Victoria (Vic) 301; Western Australia (WA) 140; Queensland
(Qld) 85; South Australia (SA) 77; Tasmania (Tas) 34; Australian Capital Territory (ACT) 21;
and the Northern Territory (NT) 15.
Of the 1,025 isolates, 979 were categorized into 75 previously reported STs. The remaining
46 isolates consisted of 43 new MLST profiles which were designated a ST by the MLST data-
base curator (https://pubmlst.org/efaecium/). From the BURST model (S1 Fig), 95.8% of
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isolates (982/1025), which included 83 STs were grouped into CC17. Thirty-two STs (40 iso-
lates) were grouped into CC94 with ST94 identified as the founder. The three remaining iso-
lates were singletons and a doubleton. Overall, 11 STs (ST17, ST18, ST78, ST80, ST192, ST203,
ST262, ST555, ST796, ST1421 and ST1424) were considered as major STs (� 20 isolates) and
all belonged to CC17 (Table 1).
Of the 11 major STs, ST1421 and ST796 had the most number of isolates with 149 and
159 isolates respectively. Over the three years, the number of isolates identified as ST17 and
ST1424 increased the most per year from 17 to 60 and 5 to 45 isolates respectively. Conversely,
the number of isolates identified as ST555 and ST203 decreased the most per year from 43 to
17 and 33 to 10 isolates respectively.
From the BURST analysis, the recently reported pstS-absent STs [30] were identified in
three different branches within CC17 and were separated by at least three ST nodes. The larg-
est group of pstS-absent STs consisted of ST1421 as the founder with ST1422, ST1423, ST1478,
ST1553 and ST1558 as single locus variants (SLVs). ST1424 and ST1559 formed the second
group while the third group consisted of a single ST1545 isolate.
Sixty-one virulence factors were identified, of which nine were present in five or more
isolates. The nine predominant virulence factors identified were: cpsF (encodes cleavage and
polyadenylation specific factor); ecbA (encodes a collagen type-V binding microbial surface
component recognizing adhesive matrix molecule [MSCRAMM]); fss3 (encodes a fibrino-
gen-binding MSCRAMM); psaA (encodes pneumococcal surface adhesion A); sgrA (encodes
a LPxTG surface adhesion that binds to fibrinogen and nidogen and is commonly implicated
in biofilm formation); acm (encodes a collagen binding MSCRAMM); bsh (encodes bile salt
hydrolase), bopD (putatively encodes a sugar-binding transcriptional regulator critical for
the process of biofilm); and clpP (encodes the ClpP protease) were. The average number of
predominant virulence factors identified per isolate was 5.2. The percentage of isolates har-
bouring the nine predominant virulence factors for the eleven major STs is summarized
in S1 Table.
Twenty-six antimicrobial resistance genes were identified of which 20 were present in five
or more isolates. The 20 predominant antimicrobial resistance genes identified were: aadE, aac
(6')-aph(2''), ant(6)-Ia, aph(2'')-Ie,aph(3')-III and spc encoding aminoglycoside resistance; cat
(pC221) and cat encoding chloramphenicol resistance; tet(S), tet(L), tet(M), tet(U) encoding
tetracycline resistance; erm(A), erm(B) and erm(T) encoding macrolide, lincosamide and strep-
togramin B resistance; vanA and vanB encoding glycopeptide resistance; lnu(B) encoding linco-
samide resistance; dfrG encoding trimethoprim resistance; and msrC encoding erythromycin,
macrolide and streptogramin B resistance. The average number of predominant resistance
genes identified per isolate was 6.7. The percentage of isolates harbouring the 20 predominant
antimicrobial resistance genes for the 11 major STs is summarized in S2 Table. Vancomycin
resistance in isolates from all three years was limited to the vanA and vanB operon. Neither
vanM nor the vertically transmitted vanC operons were identified. The proportion of E. faecium
isolates harbouring the vanA operon increased throughout the study period from 17.2% in
Table 1. Eleven major sequence types (�20 isolates) identified in the Australian Group on antimicrobial resistance Australian Enterococcal Sepsis Outcome Pro-
gram 2015–2017.
ST17 ST18 ST78 ST80 ST192 ST203 ST262 ST555 ST796 ST1421 ST1424
2015 17 5 21 28 9 33 9 43 66 45 5
2016 40 4 11 40 5 20 9 31 47 52 16
2017 60 11 10 35 7 10 3 17 46 52 50
Total 117 20 42 103 21 63 21 91 159 149 71
https://doi.org/10.1371/journal.pone.0228781.t001
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2015 to 22.3% in 2017 while the proportion of isolates harbouring the vanB operon decreased
from 38.3% in 2015 to 25.2% in 2017. The geographical distribution of the proportions of van
operon was different for each state and mainland territory (Table 2).
A maximum likelihood phylogenetic tree was constructed based on 35,058 core single nucleo-
tide polymorphisms (SNPs) to determine the relatedness between isolates (Fig 1). The root of the
tree was placed at the most distantly related isolate (E31901_2017). Three major clusters were
observed. From the phylogenetic tree, the major STs 78, 192, 203, 262, 555, 796, 1421 appeared
in one cluster; while STs, 17, 18, 80 and 1424 appeared in more than one cluster (Table 3).
Of the three clusters, cluster 1 harboured the fewest isolates, having only 134 isolates (Fig
2). However in terms of STs, cluster 1 was the most diverse with 84 unique STs including the
major STs 17, 18 and 80. Cluster 1 isolates could be divided into two sub-clusters: 1A and 1B.
Sub-cluster 1A consisted of 30 isolates with eight STs, all members of CC17, and included the
major STs 17, 18 and 80. Sub-cluster 1B consisted of 104 isolates with 76 STs and included all
CC94 isolates, which accounted for 38.5% of isolates in the sub-cluster and, the three non-
CC94/CC17 isolates. No isolates from the major STs were identified in sub-cluster 1B.
Isolates from sub-cluster 1A harboured an average of 4.8 antimicrobial resistance genes. All
isolates in sub-cluster 1A harboured msrC and more than 80% of isolates harboured tet(L) and
Table 2. The percentage of van genotypes across Australian states and mainland territories.
ACT NSW NT Qld SA Tas Vic WA
vanA 47.6 38.6 0.0 10.6 3.9 2.9 12.6 6.4
vanB 4.8 13.1 73.3 32.9 46.8 32.4 53.8 8.6
van negative 47.6 48.3 26.7 56.5 49.4 64.7 33.6 85.0
https://doi.org/10.1371/journal.pone.0228781.t002
Fig 1. Maximum likelihood phylogenetic tree based on single nucleotide polymorphisms grouped all Enterococcus faecium
isolates into three clusters. From the outermost ring: Number of virulence factors, number of antimicrobial resistance genes not
including the van operon, type of van operon and major sequence types are highlighted as per legend.
https://doi.org/10.1371/journal.pone.0228781.g001
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Table 3. Isolate characteristics based on the three phylogenetic clusters.
Cluster Sub-
cluster








1 A 30 ST17, ST18 and ST80 23.1 1.9 (0.6–5.7) 4.8 5.2
B 104 - 13.6 ref 1.6 4.0
2 A 54 ST17, ST18 and ST262 24.5 2.1 (0.8–5.2) 4.7 5.2
B 85 ST80, ST1421 and ST1424 32.5 3.1 (1.4–7.0) 5.3 5.7
C 222 ST17, ST1421 and ST1424 33.0 3.1 (1.6–6.6) 6.9 7.7
3 A 73 ST17, ST80, ST192, ST203
and ST1424
24.3 2.0 (0.9–4.8) 5.2 7.5
B 69 ST17, ST80 and ST192 23.9 2.0 (0.9–4.8) 4.0 7.7
C 71 ST203 17.2 1.3 (0.5–3.3) 5.7 7.4
D 18 ST18 43.8 4.9 (1.5–16.2) 5.8 6.8
E 86 ST17 and ST555 25.3 2.2 (1.0–5.0) 5.4 6.9
F 214 ST78, ST80, ST203, ST555
and ST796
26.6 2.3 (1.2–4.9) 5.6 6.9
1 STs with 20 or more isolates
2 where the patient 30-day all-cause mortality was known
https://doi.org/10.1371/journal.pone.0228781.t003
Fig 2. Maximum likelihood phylogenetic tree of cluster 1 isolates. From the outermost ring: Number of virulence factors, number
of resistance genes not including the van operon, type of van operon and sequence types are highlighted as per legend.
https://doi.org/10.1371/journal.pone.0228781.g002
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dfrG. No isolate in sub-cluster 1A harboured the aadE, cat(pC221) or tet(S) antimicrobial
resistance genes. The vanA and vanB operon was identified in 6.7% and 10.0% of isolates
respectively. No isolate harboured both van operons. Sub-cluster 1A isolates harboured an
average of 5.2 virulence factors. All isolates in sub-cluster 1A harboured the acm, bsh and clpP
and more than 80% harboured bopD and sgrA. No isolates in sub-cluster 1A harboured the
cpsF virulence factor. When known, the 30-day all-cause mortality of patients with sub-cluster
1A isolates was 23.1%. When compared to sub-cluster 1B, which had the lowest mortality of all
sub-clusters at 13.6%, the odds ratio for mortality was calculated at 1.9 (CI: 0.6–5.7). The dif-
ference in 30-day all-cause mortality between sub-clusters 1A and 1B was not significant
(p = 0.25).
Isolates from sub-cluster 1B harboured an average of 1.6 antimicrobial resistance genes.
More than 80% of isolates harboured msrC. No isolates in sub-cluster 1B harboured the vanA,
vanB, ant(6)-la, aph(2”)-le and tet(S) resistance genes. Sub-cluster 1B isolates harboured an
average of 4.0 virulence factors. All isolates harboured bopD and clpP, and more than 80% har-
boured bsh. None of the isolates in sub-cluster 1B harboured the psaA virulence factor.
Cluster 2 consisted of 361 isolates with 22 STs, all part of CC17, and included five major
STs: 18, 262, 80, 1424, 1421 (Fig 3). Cluster 2 isolates could be divided into three sub-clusters:
2A, 2B and 2C. Sub-cluster 2A, consisted of 54 isolates with six STs including the major STs
17, 18 and 262. Isolates from sub-cluster 2A were collected from all Australian regions except
the ACT. Sub-cluster 2B, consisted of 85 isolates with 12 STs including major STs 1421, 1424
and 80. Isolates from sub-cluster 2B were collected from across Australia. Sub-cluster 2C, con-
sisted of 222 isolates with eight STs including major STs 17, 1421 and 1424. Isolates from sub-
cluster 2C were only collected from NSW, Vic, SA and the ACT.
Fig 3. Maximum likelihood phylogenetic tree of cluster 2 isolates. From the outermost ring: Number of virulence factors, number
of resistance genes not including the van operon, type of van operon and sequence types are highlighted as per legend.
https://doi.org/10.1371/journal.pone.0228781.g003
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Isolates from sub-cluster 2A harboured an average of 4.7 antimicrobial resistance genes.
All isolates in sub-cluster 2A harboured msrC and more than 80% of isolates harboured dfrG.
No isolate in sub-cluster 1A harboured aph(2”)-le, erm(A), tet(S) or spc. The vanA and vanB
operon was identified in 1.9% and 16.7% of isolates respectively. Sub-cluster 2A isolates har-
boured an average of 5.2 virulence factors. All isolates in sub-cluster 2A harboured acm, bopD,
bsh and clpP. None of the remaining predominant virulence factors were identified in more
than 80% of isolates. No isolate in sub-cluster 2A harboured cpsF. When known, the 30-day
all-cause mortality of patients with 2A isolates was 24.5%. Compared to sub-cluster 1B isolates
the odds ratio for mortality was calculated at 2.1(CI: 0.5–5.2). The difference in 30-day all-
cause mortality between sub-clusters 2A and 1B was not significant (p = 0.12).
Isolates from sub-cluster 2B harboured an average of 5.3 antimicrobial resistance genes. All
isolates in sub-cluster 2B harboured msrC and more than 80% of isolates harboured dfrG. No
isolates in sub-cluster 2B harboured aph(2”)-le or cat. The vanA and vanB operon was identi-
fied in 28.2% and 14.1% of isolates respectively. Sub-cluster 2B isolates harboured an average
of 5.7 virulence factors. All isolates in sub-cluster 2B harboured bopD and clpP and more than
80% of isolates harboured acm, bsh and sgrA. No isolates in sub-cluster 2B harboured the cpsF
virulence factor. When known, the 30-day all-cause mortality of patients with sub-cluster 2B
isolates was 32.5%. Compared to sub-cluster 1B isolates the odds ratio for mortality was calcu-
lated at 3.1 (CI: 1.4–7.0). The difference in 30-day all-cause mortality between sub-clusters 2B
and 1B was significant (p = 0.005).
Isolates from sub-cluster 2C harboured an average of 6.9 antimicrobial resistance genes.
More than 80% of isolates harboured dfrG, erm(A), erm(B), msrC, spc and aph(3’)-III. No
isolates in sub-cluster 2C harboured aadE, ant(6)-la, aph(2”)-le, cat(p221), cat, lnu(B) or tet(S).
The vanA and vanB operon was identified in 68.0% and 0.9% of isolates respectively. Sub-clus-
ter 2C isolates harboured an average of 7.7 virulence factors. All isolates in sub-cluster 2C har-
boured acm, bopD and clpP and more than 80% of isolates harboured bsh, ecbA, fss3, psaA
and sgrA. No isolates in sub-cluster 2A harboured the cpsF virulence factor. When known,
the 30-day all-cause mortality of patients with sub-cluster 2C isolates was 33.0%. Compared
to sub-cluster 1B isolates the odds ratio for mortality was calculated at 3.1 (CI: 1.6–6.6).
The difference in 30-day all-cause mortality between sub-clusters 2C and 1B was significant
(p = 0.001).
Cluster three was the largest cluster consisting of 530 isolates with 20 STs (Fig 4). All STs
identified in cluster 3 were part of CC17 and included the major STs 17, 78, 80, 203, 555, 796,
1424, 1421. Cluster 3 isolates could be divided into six sub-clusters: 3A to 3F. Sub-cluster 3A,
consisted of 73 isolates with six STs including the major STs 17, 80, 192, 203 and 1424. Isolates
from sub-cluster 3A were collected from all Australian regions except SA, ACT and NT. Sub-
cluster 3B, consisted of 69 isolates with three STs including the major STs 17, 80 and 192. Iso-
lates from sub-cluster 3B were collected from all Australian regions except NSW, Vic and
ACT. Sub-cluster 3C, consisted of 71 isolates with seven STs including the major ST ST203.
Isolates from sub-cluster 3C were collected from all Australian regions except the NT. Sub-
cluster 3D, consisted of 18 isolates with four STs including the major STs 18 and 80. Isolates
from sub-cluster 3D were collected from all Australian regions except the NT and ACT. Sub-
cluster 3E, consisted of 86 isolates, with two major STs 17 and 555. Isolates from sub-cluster
3E were collected from all Australian regions except the ACT, Qld and Vic. Sub-cluster 3F,
consisted of 214 isolates, with eight STs including the major STs 78, 80, 203, 555 and 796. Iso-
lates from sub-cluster 3F were collected from all Australian regions except the ACT.
Isolates from sub-cluster 3A harboured an average of 5.2 antimicrobial resistance genes. All
isolates in sub-cluster 3A harboured msrC and more than 80% of isolates harboured ant(6)-IA,
aph(3”)-III and erm(B). No isolates in sub-cluster 3A harboured aadE, aph(2”)-le, cat(p221),
Genomic characteristics of E. faecium
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cat, erm(A) or spc. The vanA and vanB operon was identified in 19.2% and 15.1% of isolates
respectively. Sub-cluster 3A isolates harboured an average of 7.5 virulence factors. All isolates
in sub-cluster 3A harboured acm, bopD and fss3 and more than 80% of isolates harboured bsh,
clpP, psaA and sgrA. No isolates in sub-cluster 3A harboured the cpsF virulence factor. When
known, the 30-day all-cause mortality of patients with sub-cluster 3A isolates was 24.3%. Com-
pared to sub-cluster 1B isolates the odds ratio for mortality was calculated at 2.0 (CI: 0.9–4.8).
The difference in 30-day all-cause mortality between sub-clusters 3A and 1B was not signifi-
cant (p = 0.10).
Isolates from sub-cluster 3B harboured an average of 4.0 antimicrobial resistance genes. All
isolates in sub-cluster 3B harboured msrC and more than 80% of isolates harboured aph(3’)-III
and erm(B). No isolate in sub-cluster 3B harboured aadE, aph(2”)-Ie, cat(p221), cat, erm(A),
erm(T), spc or tet(L). The vanA and vanB operon was identified in 11.2% and 2.9% of isolates
respectively. Sub-cluster 3B isolates harboured an average of 7.7 virulence factors. All isolates
in sub-cluster 3B harboured acm, bopD and clpP and more than 80% of isolates harboured bsh,
fss3, psaA and sgrA. No isolates in sub-cluster 3B harboured the cpsF virulence factor. When
known, the 30-day all-cause mortality of patients with sub-cluster 3B isolates was 23.9%. Com-
pared to sub-cluster 1B isolates the odds ratio for mortality was calculated at 2.0 (CI: 0.9–4.8).
The difference in 30-day all-cause mortality between sub-clusters 3B and 1B was not signifi-
cant (p = 0.11).
Isolates from sub-cluster 3C harboured an average of 5.7 antimicrobial resistance genes.
All isolates in sub-cluster 3C harboured msrC and more than 80% of isolates harboured erm
(B) and tet(M). No isolates in sub-cluster 3C harboured aadE, aph(2”)-le, cat, erm(A), erm(T),
Fig 4. Maximum likelihood phylogenetic tree of isolates in cluster 3. From the outermost ring: Number of virulence factors,
number of resistance genes not including the van operon, type of van operon and sequence types are highlighted as per legend.
https://doi.org/10.1371/journal.pone.0228781.g004
Genomic characteristics of E. faecium
PLOS ONE | https://doi.org/10.1371/journal.pone.0228781 February 14, 2020 9 / 15
spc, tet(L) or tet(S). The vanA and vanB operon was identified in 12.9% and 47.1% of isolates
respectively. Sub-cluster 3C isolates harboured an average of 7.4 virulence factors. All isolates
in sub-cluster 3C harboured acm, bsh and clpP and more than 80% of isolates harboured
bopD, fss3, psaA and sgrA. No isolate in sub-cluster 3B harboured the cpsF virulence factor.
When known, the 30-day all-cause mortality of patients with sub-cluster 3C isolates was
17.2%. Compared to sub-cluster 1B isolates the odds ratio for mortality was calculated at 1.3
(CI: 0.5–3.3). The difference in 30-day all-cause mortality between sub-clusters 3C and 1B was
not significant (p = 0.55).
Isolates from sub-cluster 3D harboured an average of 5.8 antimicrobial resistance genes. All
isolates in sub-cluster 3D harboured msrC and more than 80% of isolates harboured ant(6)-Ia,
aph(3”)-III and erm(B). No isolates in sub-cluster 3D harboured aadE, aph(2”)-Ie, cat(pC221),
erm(A), lnu(B), spc or tet(S). The vanA and vanB operon was identified in 5.6% and 11.1% of
isolates respectively. Sub-cluster 3D isolates harboured an average of 6.8 virulence factors. All
isolates in sub-cluster 3D harboured acm, bopD and clpP and more than 80% of isolates har-
boured bsh, psaA and sgrA. No isolates in sub-cluster 3D harboured the cpsF virulence factor.
When known, the 30-day all-cause mortality of patients with 3D isolates was 43.8%. Compared
to sub-cluster 1B isolates the odds ratio for mortality was calculated at 4.9 (CI: 1.5–16.2).
The difference in 30-day all-cause mortality between sub-clusters 3D and 1B was significant
(p = 0.008).
Isolates from sub-cluster 3E harboured an average of 5.4 antimicrobial resistance genes. All
isolates in sub-cluster 3E harboured msrC and more than 80% of isolates harboured dfrG and
erm(B). No isolates in sub-cluster 3E harboured aadE, aph(2”)-Ie, cat(pC221), cat, vanA or tet
(S). The vanB operon was identified in 48.8% of isolates. The vanA operon was not identified
in sub-cluster 3E. Sub-cluster 3E isolates harboured an average of 6.9 virulence factors. All iso-
lates in sub-cluster 3E harboured bopD, bsh, clpP and fss3 and more than 80% of isolates har-
boured acm, psaA and sgrA. No isolates in sub-cluster 3E harboured the cpsF or ecbA virulence
factors. When known, the 30-day all-cause mortality of patients with sub-cluster 3E isolates
was 25.3%. Compared to sub-cluster 1B isolates the odds ratio for mortality was calculated at
2.2(CI: 1.0–5.0). The difference in 30-day all-cause mortality between sub-clusters 3E and 1B
was not significant (p = 0.06).
Isolates from sub-cluster 3F harboured an average of 5.6 antimicrobial resistance genes. All
isolates in sub-cluster 3F harboured msrC and more than 80% of isolates harboured dfrG, erm
(B) and vanB. No isolates in sub-cluster 3F harboured the aadE resistance gene. The vanA and
vanB operon was identified in 0.9 and 92.1% of isolates respectively. Sub-cluster 3F isolates har-
boured an average of 6.9 virulence factors. All isolates in sub-cluster 3F harboured bsh and clpP
and more than 80% of isolates harboured acm, bopD, fss3, psaA and sgrA. When known, the
30-day all-cause mortality of patients with sub-cluster 3F isolates was 26.6%. Compared to sub-
cluster 1B isolates the odds ratio for mortality was calculated at 2.3(CI: 1.2–4.9). The difference
in 30-day all-cause mortality between sub-clusters 3F and 1B was significant (p = 0.02).
Geographically, the distribution of van genes and sequence types varied. In NSW, 38.6%
and 13.1% of isolates harboured the vanA and vanB operon respectively. An additional isolate
harboured both vanA and vanB operons. The most frequent ST amongst the NSW isolates was
ST1421 accounting for 32.4% of isolates. Overall, 54% of isolates from NSW were identified in
sub-cluster 2C.
In Vic, 12.6% and 53.8% of isolates harboured the vanA and vanB operon respectively.
An additional five isolates harboured both the vanA and vanB operons. Except for a pair of
closely related ST80 isolates, isolates harbouring both operons were from different STs and
unrelated phylogenetically. The most frequent ST amongst the Vic isolates was ST796 account-
ing for 44.5% of isolates. Overall, 47.2% of isolates from Vic were identified in sub-cluster 3D.
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In Qld, 10.6% and 32.9% of isolates harboured the vanA and vanB operon respectively. The
most frequent ST amongst the Qld isolates was ST17 accounting for 29.4% of isolates. Overall,
23.5% and 22.4% of isolates from Qld were identified in sub-cluster 3A and 3F respectively.
In WA, only 6.4% and 8.6% of isolates harboured the vanA and vanB operon respectively.
The most frequent ST amongst the WA isolates was ST17 accounting for 35% of isolates. Over-
all, 40.0% of isolates from WA were identified in sub-cluster 3B.
In SA, 3.9% and 46.8% of isolates harboured the vanA and vanB operon respectively. The
most frequent ST amongst the SA isolates was ST555 accounting for 45.5% of isolates. Overall,
45.5% of isolates from SA were identified in sub-cluster 3E.
In Tas, 2.9% and 32.4% of isolates harboured the vanA and vanB operon respectively. The
most frequent ST amongst the Tas isolates was ST796 accounting for 29.4% of isolates. Overall,
23.5% of isolates from Tas were identified in sub-cluster 3B.
In the NT, 73.3% of isolates harboured the vanB operon. The most frequent ST amongst the
NT isolates was ST555 accounting for 66.7% of isolates. Overall, 66.7% of isolates from NT
were identified in sub-cluster 3E.
In the ACT, 47.6% and 4.8% of isolates harboured the vanA and vanB operon respectively.
The most frequent ST amongst the ACT isolates was ST1421 accounting for 57.1% of isolates.
Overall, 61.9% of isolates from ACT were identified in sub-cluster 2C.
Discussion
In 2011, 36.5% of Australian E. faecium bacteraemia isolates were identified as vancomycin
non-susceptible, of which 98.4% harboured the vanB operon [31]. Supported by AESOP
reports, the high prevalence of VREfm has been a growing trend in Australian hospitals over
the last decade. In this study, we employed WGS as a screening tool in the surveillance of
1,025 BSI associated E. faecium collected across Australia from 2015 to 2017. Using bioinfor-
matics, we have demonstrated E. faecium epidemiology is heterogenous across Australia
with a mixture of strains harbouring unique genetic compositions that are constantly evolv-
ing in each region. When studied on a national level, Australian E. faecium BSI isolates can
be classified into three broad molecular clusters and further divided into eleven sub-clusters.
In addition, by pairing genomic features with molecular phylogeny we have identified key
phylogenetic clusters with increased clinical significance with respect to 30-day all-cause
mortality.
Focusing on the high prevalence of VREfm in Australia, the majority of vancomycin resis-
tant isolates were associated with sub-clusters 2 and 3. Within clusters 2 and 3, sub-clusters 2C
and 3F had the highest proportion of vancomycin resistant isolates. Aside from the high van
operon carriage, sub-cluster 2C had the most number of isolates, the highest number of aver-
age antimicrobial resistance and virulence genes per isolate, and the second highest 30 day all-
cause mortality. Similarly, sub-cluster 3F, which had the second highest number of isolates,
harboured a higher than average number of antimicrobial resistance and virulence genes. Con-
versely, isolates in sub-cluster 1B had the lowest numbers of antimicrobial resistance and viru-
lence genes and the lowest 30-day all-cause mortality.
Comparing sub-clusters, we observed an increase in the number of clonal isolates, namely
ST1421 and ST796, in the two van operon dominant sub-clusters, 2C and 3F respectively. In
contrast we observed a low clonality of isolates and the absence of the van operon in sub-clus-
ter 1B. Other than a high prevalence of the van operon, we were not able to identify additional
antimicrobial resistance or virulence genes that offered sub-clusters 2C and 3F an advantage
over the other sub-clusters. A significant difference in the 30-day all-cause mortality was
observed in the four predominant VREfm sub-clusters (2B, 2C, 3D and 3F) compared to sub-
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cluster 1B. The findings suggests the presence of van operons contribute to the success of the
clone and the increased 30-day all-cause mortality observed.
In sub-clusters 2C and 3F, we observed a dominance of the vanA operon and vanB operon
respectively. However, the dominance of a particular van operon was not observed throughout
a cluster. From the phylogenetic tree of clusters 2 and 3, basal isolates in sub-clusters 2A and
3A predominantly harboured a mixture of van operon type. With the exception of sub-cluster
3B, when moving further from the root in clusters 2 and 3, a gradual and sequential increase in
the prevalence of a particular van operons was observed suggesting an increasing affinity
between isolates and the dominant van operon type for that cluster.
Over the three-year study period, we observed a decrease in the proportion of isolates har-
bouring the vanB operon but an increase in isolates harbouring the vanA operon. The result,
coupled with the 2011 report identifying a 98.4% prevalence in vanB type VREfm[32], indi-
cates a shift in trend towards vanA VREfm in Australia.
Although E. faecium isolates were collected from every region in Australia, limitations of
this study include the difference in the number of participating laboratories and population
demographics in each region. Additionally, frequent patient transfers between NT and SA,
Tas and Vic, and the ACT and NSW, has resulted in major cross regional movement of
patients. Therefore, in this study, we are unable to make accurate observations comparing the
regional distribution of isolates across Australia. However, for most regions, we did observe
specific region-dominant sub-clusters accounting for at least 45% of isolates. Additionally, we
observed isolates from cluster 2C were collected in the fewest locations (NSW, Vic, SA and
ACT) suggesting a more confined geographical distribution. A further limitation of the study
was the clinical data of the patients was not available and therefore could not be analysed.
In our study, we observed several discrepancies between the relationship of STs described
by the BURST diagram compared to SNP based molecular phylogeny. For example, isolates
in sub-cluster 2C typed as ST1421 and ST1424 and isolates in sub-cluster 3F typed as ST203
and ST796 were observed to be distantly related by BURST but closely related by SNP phy-
logeny. SNP inferred isolate relationship offers a much higher resolution. As such, the use
of BURST modelling may not be accurate in depicting relationships between E. faecium
strains.
In conclusion, our study has shown E. faecium isolates from 2015 to 2017 causing BSI in
Australia could be classified into three phylogenetic clusters. Moreover, each cluster can be
characterized by a dominant van operon (or the lack of one) which we have shown to be key
in the dissemination of isolates. Our findings also show, unlike in 2011 when VREfm in Aus-
tralia was primarily due to the vanB operon, the presence of a highly successful vanA dominant
strain identified in sub-cluster 2C have resulted in the co-dominance of vanA and vanB
VREfm in Australia. Our analysis has highlighted clinically important strains of E. faecium in
sub-cluster 2C and 3F which should be closely monitored in future surveillance. With the phy-
logeny of VREfm in Australia established in this study, future surveillance can now identify
the introduction or emergence of new E. faecium strains with a much higher resolution com-
pared to MLST. Additionally, with regular timely monitoring, individual hospitals can use the
detection of clinically important VREfm strains, such as those identified in sub-cluster 2C and
3F as early warnings of potential outbreaks and therefore appropriate infection control proce-
dures could be commenced earlier than previously. As E. faecium is an emerging nosocomial
pathogen with extended antibiotic resistance, an online resource offering rapid typing and
phylogenetic relatedness linked to antibiotic resistance genes and clinical data would be very
useful [33]. Further studies of the van operon and genes associated with the operon will con-
tribute to our understanding of the evolution of enterococci in the hospital environment and
assist in the implementation of successful control strategies.
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